cp wire

CP Wire Articles

Boehringer Ingelheim Licenses Novel TCRm Antibody for Cancer Treatment



Eureka Therapeutics Inc. announced on 7/17/18 that Boehringer Ingelheim has elected to exercise an option for the exclusive license of... read more

Tue, 07/17/18 - 09:25 am
Verge Genomics Scores $32 Million for AI-Driven Drug Discovery

Verge Genomics, a drug discovery company utilizing machine learning to develop new therapeutics, announced today that it has raised $32 million in Series A financing led by DFJ. New biotech... read more

Mon, 07/16/18 - 09:20 am
Ironwood Initiates Ph III Study of Linaclotide in IBS-C

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced  on 7/16/18 the initiation of a Phase IIIb clinical trial evaluating the efficacy and safety of linaclotide 290 mcg on multiple abdominal... read more

Mon, 07/16/18 - 09:06 am
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
  • Total development agreement could be worth up to $275 million
  • AB928 has the potential to reverse adenosine-induced immune suppression within the tumor microenvironment

... read more

Fri, 07/13/18 - 09:28 am
Advaxis Shares Jump After FDA Lifts Clinical Hold on Phase 1/2 Study
  • Shares up 38%+ in pre-market trading
  • Clinical Hold was issued on March 9, 2018
  • Axalimogene filolisbac has fast track designation for adjuvant therapy for high-risk locally... read more
Fri, 07/13/18 - 09:05 am

Pages